Expert-Grade Biomedical Compliance Insights for Medical Device Teams

This AI Transformation performs a controlled, review-period-bound web evidence surveillance process for the Guardant Shield colorectal cancer screening test across only the external sources authorized for the review. It converts regulatory, clinical, scientific, comparator, and patient/provider evidence into structured, traceable clinical evidence intelligence while maintaining strict separation between Shield-specific findings, comparator and technology context, experience signals, and excluded evidence. The transformation evaluates source coverage, product attribution, clinical performance, regulatory developments, evidence trends, clinical literature, safety signals, documented risks, claims, intended purpose, benefit-risk evidence, and evidence gaps. It also provides CER document-control information, stakeholder review routing, and a traceable evidence appendix for human Clinical, Regulatory, Medical Affairs, Quality, and Risk Management review.

This AI Transformation runs a bounded, SOP-governed web evidence search across regulatory, clinical, scientific, and public-experience sources to identify new clinical, performance, safety, and evidence information relevant to the Guardant Shield colorectal cancer screening test within a defined review period. It classifies each finding based on product attribution, evidence reliability, clinical relevance, and impact on the existing clinical evidence profile, producing a structured evidence surveillance output — including evidence findings, performance signals, trend analysis, benefit-risk considerations, further evidence recommendations, and stakeholder review actions for human Clinical, Regulatory, Medical Affairs, and Quality review.

This AI Transformation analyzes a medical device Quality Manual against up to three uploaded regulatory and quality standards, converting manual content, regulatory references, documented processes, and standard clause text into structured, evidence-based cross-standard regulatory intelligence across 16 analytical dimensions. It surfaces key signals such as QMS scope and exclusions, the documented regulatory baseline, cross-standard requirement alignment and divergence, terminology relationships, requirement coverage status, traceability strength, prioritized coverage gaps, and standard edition consistency — each calibrated to how confidently it can be asserted from the provided evidence. This supports Regulatory Affairs leadership, Quality Assurance leadership, quality systems management, document control, internal audit, and executive oversight with faster, clearer, and fully traceable cross-standard mapping intelligence.

This AI Transformation runs a bounded, SOP-governed search across regulatory, clinical, and public-sentiment sources to identify new safety and clinical information relevant to a specified contact lens device within a defined date range, classifies each finding against FDA and EU MDR reporting criteria, and produces a structured, source-attributed CER-oriented output — including reportability recommendations, non-conformance flags, trend analysis, and required stakeholder actions, for human Regulatory/QA review.